Daxor Corporation Common Stock (DXR) Stock Price

DXRStock
$10.0018.14%52W
Market Cap$58.38M
P/E6.42x
PEG Ratio
Div yield
Beta0.35

DXR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-32.39%
Price vs S&P 500 (4W)-11.91%
VGM Score35.00
P/E Ratio (Annual)6.42x

DXR Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.00
4.00
4.00
4.00

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
DXRDaxor Corporation Common Stock
DDC$10.00
SYKStryker CorporationCBC$330.59
MMM3M CompanyCDB$179.37
BSXBoston Scientific Corp.CBD$49.86
BDXBecton, Dickinson and Co.BDB$189.78
MDLNMedline Inc. Class A common stockCDC$35.64
RMDResMed Inc.CBC$236.59
DXCMDexCom, Inc.DBB$89.16
WSTWest Pharmaceutical Services, Inc.DCB$348.48
SOLVSolventum CorporationCCB$91.61
BAXBaxter International Inc.BDB$26.29

About Daxor Corporation Common Stock

Daxor Corp is a medical instrumentation company specializing in blood volume diagnostics. The company develops and markets the BVA-100 (Blood Volume Analyzer), an FDA-cleared diagnostic tool that provides accurate, objective measurement of blood volume status and composition across a broad range of medical conditions. By comparing results to patient-specific norms, the BVA-100 enables clinicians to make data-driven treatment decisions.